e-learning
resources
Berlin 2008
Monday, 06.10.2008
Diagnostic aspects in thoracic oncology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Use of carcinoembryonic antigen in pleural effusion for differential diagnosis of benign and malignant pleural effusion
T. Radjenovic Petkovic, T. Pejcic, D. Nastasijevic, M. Rancic, M. Radovic, I. Djordjevic, M. Cekic (Nis, Serbia And Montenegro)
Source:
Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Session:
Diagnostic aspects in thoracic oncology
Session type:
Thematic Poster Session
Number:
2623
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Radjenovic Petkovic, T. Pejcic, D. Nastasijevic, M. Rancic, M. Radovic, I. Djordjevic, M. Cekic (Nis, Serbia And Montenegro). Use of carcinoembryonic antigen in pleural effusion for differential diagnosis of benign and malignant pleural effusion. Eur Respir J 2008; 32: Suppl. 52, 2623
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 775s
Year: 2006
Combined pleural CRP and chest ultrosonography for discrimination between tuberculous and malignant pleural effusion
Source: Eur Respir J 2005; 26: Suppl. 49, 414s
Year: 2005
Management of malignant pleural effusion
Source: Eur Respir J 2001; 18: Suppl. 33, 397s
Year: 2001
Pleurodesis for malignant pleural effusion
Source: ERS Course 2016 - Skills course on medical thoracoscopy
Year: 2016
Pleurodesis for malignant pleural effusion
Source: School Course 2014 - Medical Thoracoscopy
Year: 2014
Transudative malignant pleural effusions
Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Year: 2019
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020
Closed pleural brushing in the diagnosis of malignant pleural effusions
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008
Videothoracoscopy in the treatment of malignant pleural effusions
Source: Annual Congress 2009 - Pleural and mediastinal diseases
Year: 2009
Management of malignant pleural effusions
Source: Eur Respir J 2001; 18: 402-419
Year: 2001
Management of malignant pleural effusions
Source: Guideline 2001
Year: 2001
Management of malignant pleural effusions
Source: ERS Skills course: Multi-disciplinary care in thoracic oncology
Year: 2019
Separating malignant from nonmalignant pleural effusion on the basis of
P
O
2
in pleural effusion
Source: Eur Respir J 2003; 22: Suppl. 45, 541s
Year: 2003
Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
Pleurodesis in the treatment of malignant pleural effusion
Source: Eur Respir J 2004; 24: Suppl. 48, 628s
Year: 2004
Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012
Closed pleural needle biopsy and pleural fluid examination in pathological diagnosis of malignant pleural effusion
Source: Eur Respir J 2003; 22: Suppl. 45, 256s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept